[Lumbar disk prolapse treated with chymopapain].
We report results from 108 consecutive patients followed up for one year after chymopapain injection. The patients were selected on strict clinical and radiological criteria. In nine patients (8%) the result was poor, and they were surgically treated within one year after the injection. 99 (92%) patients improved and after one year 87 of these (81% of the total material) had returned full time to their previous occupation. The only serious complication was one case of septicemia and possible discitis. The patient made a full recovery after antibiotic treatment. On the basis of these results, we shall continue to use chymopapain injection to treat selected patients with sciatica caused by herniated lumbar discs.
Brautaset
N J
NJ
Nevrologisk avdeling, Regionsykehuset i Trondheim.
Hemminghytt
S
S
Henriksen
O A
OA
Sand
T
T
D000293:Adolescent; D000328:Adult; D002917:Chymopapain / Q000627:therapeutic use*; D000075202:Contraindications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007404:Intervertebral Disc Chemolysis / Q000009:adverse effects / Q000379:methods*; D007405:Intervertebral Disc Displacement / Q000188:drug therapy* / Q000601:surgery; D008159:Lumbar Vertebrae / Q000187:drug effects; D008297:Male; D008875:Middle Aged
D002917:Chymopapain
Lumbale skiveprolapser behandlet med kymopapain.